Melqart Asset Management (UK) Ltd Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001712901
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2024 · 52 positions · Total reported value $1.13B · Top-10 concentration 55.8% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 72.2% · 14 new · 8 cut · 17 exited
Active Share (vs S&P 500): 86.8% · vs QQQ: 79.3% — share of the book that differs from index weights (higher = more active) · ranking
In its Q2 2024 13F filing, Melqart Asset Management (UK) Ltd disclosed 52 equity positions with a combined reported value of $1.13B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 55.8% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.
The largest disclosed positions as of Q2 2024 were RSP ($101.53M), CYTK ($90.79M), CPRI ($78.99M). By sector, the heaviest allocations are Technology 22.1%, Health Care 14.4%. Versus the prior quarter, allocation shifted toward Health Care (+9.8pp), Consumer Discretionary (+6.3pp) and away from Technology (-4.3pp), Energy (-5.8pp).
Versus the prior quarter, Melqart Asset Management (UK) Ltd opened 14 new positions, trimmed 8 and fully exited 17, a turnover rate of 72.2% of positions. The portfolio's overlap with the prior quarter was 48% of names.
The largest new positions opened in Q2 2024 were CTLT ($22.36M), AMD ($17.40M), ARGX ($16.34M).
Of the 17 positions fully exited versus the prior quarter, the largest were PXD ($186.28M), XOM ($92.92M), NVDA ($46.34M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2024)
- CTLT CATALENT INC · $22.36M
- AMD ADVANCED MICRO DEVICES INC · $17.40M
- ARGX ARGENX SE · $16.34M
- NVEI NUVEI CORPORATION · $15.92M
- BMRN BIOMARIN PHARMACEUTICAL INC · $14.24M
- ROIV ROIVANT SCIENCES LTD · $13.38M
- BBIO BRIDGEBIO PHARMA INC · $7.80M
- SHOP SHOPIFY INC · $7.36M
Fully Exited (vs previous quarter)
- PXD PIONEER NAT RES CO · prev qtr: $186.28M
- XOM EXXONMOBIL HOLDINGS CORP · prev qtr: $92.92M
- NVDA NVIDIA CORPORATION · prev qtr: $46.34M · history
- JNPR JUNIPER NETWORKS INC · prev qtr: $31.93M
- DFS DISCOVER FINL SVCS · prev qtr: $16.84M
- TCN TRICON RESIDENTIAL INC · prev qtr: $16.40M
- GMED GLOBUS MED INC · prev qtr: $11.74M
- FROG JFROG LTD · prev qtr: $8.81M
Insider Transactions (Form 4)
Latest Melqart Asset Management (UK) Ltd buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Melqart Asset Management (UK) Ltd, based in London, United Kingdom, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 40 positions worth $1.05B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: LONDON, United Kingdom
- SEC registration: 801-126213 (status: Approved), registered 2022-07-29
- Regulatory AUM (Form ADV): $2.87B as of 2026-02-25
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 2 private funds, of which 2 hedge funds
- Website: melqart.com
Portfolio Structure
- 40 positions · $1.05B reported value (Q2 2026)
- Top 10 holdings = 59.8% of reported value
- Largest position: WBD (WARNER MUSIC GROUP CORP) at 11.6%
- Average position size: $26.27M
Sector Tilt
- Health Care 20.1%
- Information Technology 17.3%
- Consumer Discretionary 13.1%
- (classified holdings cover 84% of value)
Quarterly Activity
- Q2 2026: 14 new, 11 added, 15 reduced, 15 exited
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
618.00K | $101.53M | 8.97% | Hold | |
| 2 |
|
1.68M | $90.79M | 8.02% | Add | |
| 3 |
|
2.39M | $78.99M | 6.98% | Add | |
| 4 |
|
3.92M | $77.48M | 6.84% | Hold | |
| 5 |
|
202.58K | $65.13M | 5.75% | Add | |
| 6 |
|
4.83M | $60.61M | 5.36% | Add | |
| 7 |
|
310.51K | $45.81M | 4.05% | Reduce | |
| 8 |
|
1.10M | $44.95M | 3.97% | Add | |
| 9 |
|
482.93K | $33.76M | 2.98% | Add | |
| 10 |
|
351.32K | $32.25M | 2.85% | Reduce | |
| 11 |
|
586.80K | $30.22M | 2.67% | Reduce | |
| 12 |
|
361.50K | $29.28M | 2.59% | Reduce | |
| 13 |
|
1.28M | $28.19M | 2.49% | Add | |
| 14 |
|
211.19K | $27.78M | 2.45% | Reduce | |
| 15 |
|
398.62K | $22.66M | 2.00% | Add | |
| 16 |
|
332.73K | $22.37M | 1.98% | Reduce | |
| 17 |
|
397.73K | $22.36M | 1.98% | New | |
| 18 |
|
108.04K | $20.88M | 1.84% | Reduce | |
| 19 |
|
270.75K | $20.51M | 1.81% | Add | |
| 20 |
|
500.00K | $18.90M | 1.67% | Reduce | |
| 21 |
|
107.26K | $17.40M | 1.54% | New | |
| 22 |
|
29.41K | $17.35M | 1.53% | Reduce | |
| 23 |
|
38.00K | $16.34M | 1.44% | New | |
| 24 |
|
425.63K | $16.02M | 1.42% | Reduce | |
| 25 |
|
491.69K | $15.92M | 1.41% | New | |
| 26 |
|
172.95K | $14.24M | 1.26% | New | |
| 27 |
|
1.27M | $13.38M | 1.18% | New | |
| 28 |
|
298.82K | $13.37M | 1.18% | Reduce | |
| 29 |
|
450.85K | $11.61M | 1.03% | Reduce | |
| 30 |
|
75.56K | $10.21M | 0.90% | Reduce | |
| 31 |
|
110.98K | $9.02M | 0.80% | Reduce | |
| 32 |
|
307.91K | $7.80M | 0.69% | New | |
| 33 |
|
111.50K | $7.36M | 0.65% | New | |
| 34 |
|
316.19K | $6.69M | 0.59% | Reduce | |
| 35 |
|
46.99K | $6.64M | 0.59% | New | |
| 36 |
|
26.44K | $6.61M | 0.58% | Reduce | |
| 37 |
|
132.07K | $6.36M | 0.56% | Reduce | |
| 38 |
|
114.95K | $6.09M | 0.54% | New | |
| 39 |
|
8.15M | $5.65M | 0.50% | New | |
| 40 |
|
26.44K | $4.68M | 0.41% | Reduce | |
| 41 |
|
92.61K | $4.60M | 0.41% | New | |
| 42 |
|
23.47K | $4.42M | 0.39% | New | |
| 43 |
|
19.70K | $4.40M | 0.39% | New | |
| 44 |
|
275.09K | $4.23M | 0.37% | New | |
| 45 |
|
16.58K | $3.99M | 0.35% | New | |
| 46 |
|
23.08K | $3.99M | 0.35% | New | |
| 47 |
|
4.06K | $3.67M | 0.33% | New | |
| 48 |
|
92.33K | $3.63M | 0.32% | New | |
| 49 |
|
1.03M | $3.50M | 0.31% | Hold | |
| 50 |
|
13.50K | $3.28M | 0.29% | New | |
FAQ
What did Melqart Asset Management (UK) Ltd buy in 2024-Q2?
In its 2024-Q2 13F filing, Melqart Asset Management (UK) Ltd reported 52 equity positions worth $1.13B in aggregate; its largest disclosed positions were RSP ($101.53M), CYTK ($90.79M), CPRI ($78.99M).
How large is Melqart Asset Management (UK) Ltd's portfolio?
Melqart Asset Management (UK) Ltd reported $1.13B of long equity holdings across 52 positions as of 2024-Q2. Top-10 holdings account for 55.8% of reported value.
What is Melqart Asset Management (UK) Ltd's investment style?
HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.